Integrated Drug Reviews at the US Food and Drug Administration—Legal Concerns and Knowledge Lost

This Viewpoint argues against the US Food and Drug Administration’s replacement of individual scientific reviews with integrated reviews for new drug approvals.

JAMA Internal Medicine